This summary clearly suggests that E-selectin is a valid target, considering that it reduced cancer metastasis, detached them from a safe E-selectin-rich BM niche, mobilized cancer cells to the circulation, and overcame drug resistance by sensitizing cancer cells to chemotherapies. Here, SELE is linked to cancer.